Authors:
Heinonen, H
Volin, L
Uutela, A
Zevon, M
Barrick, C
Ruutu, T
Citation: H. Heinonen et al., Quality of life and factors related to perceived satisfaction with qualityof life after allogeneic bone marrow transplantation, ANN HEMATOL, 80(3), 2001, pp. 137-143
Authors:
Bjorkstrand, B
Svensson, H
Goldschmidt, H
Ljungman, P
Apperley, J
Mandelli, F
Marcus, R
Boogaerts, M
Alegre, A
Remes, K
Cornelissen, JJ
Blade, J
Lenhoff, S
Iriondo, A
Carlson, K
Volin, L
Littlewood, T
Goldstone, AH
San Miguel, J
Schattenberg, A
Gahrton, G
Citation: B. Bjorkstrand et al., Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT), BONE MAR TR, 27(5), 2001, pp. 511-515
Authors:
Parkkali, T
Kayhty, H
Lehtonen, H
Ruutu, T
Volin, L
Eskola, J
Ruutu, P
Citation: T. Parkkali et al., Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients, BONE MAR TR, 27(1), 2001, pp. 79-84
Authors:
Gahrton, G
Svensson, H
Cavo, M
Apperley, J
Bacigalupo, A
Bjorkstrand, B
Blade, J
Cornelissen, J
de Laurenzi, A
Facon, T
Ljungman, P
Michallet, M
Niederwieser, D
Powles, R
Reiffers, J
Russell, NH
Samson, D
Schaefer, UW
Schattenberg, A
Tura, S
Verdonck, LF
Vernant, JP
Willemze, R
Volin, L
Citation: G. Gahrton et al., Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres, BR J HAEM, 113(1), 2001, pp. 209-216
Authors:
Oivanen, T
Ala-Harja, K
Almqvist, A
Apajalahti, J
Elonen, E
Hallman, H
Hanninen, A
Ilvonen, M
Isomaa, B
Jouppila, J
Jarvenpaa, E
Jarventie, G
Kilpi, H
Koistinen, P
Koistinen, S
Koivisto, AM
Koivunen, E
Korpi, E
Katka, K
Kaariainen, M
Lahtinen, R
Laitinen, A
Lehtinen, M
Makela, H
Nylanden, P
Nyman, D
Palva, I
Pelliniemi, TT
Pulli, T
Rajamaki, A
Rauhala, A
Remes, K
Rosengard, S
Ruutu, T
Soininen, K
Tiilikainen, J
Timonen, T
Waris, E
Vilpo, J
Volin, L
Citation: T. Oivanen et al., Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study, EUR J HAEMA, 65(2), 2000, pp. 123-127
Authors:
Jantunen, E
Ruutu, P
Piilonen, A
Volin, L
Parkkali, T
Ruutu, T
Citation: E. Jantunen et al., Treatment and outcome of invasive Aspergillus infections in allogeneic BMTrecipients, BONE MAR TR, 26(7), 2000, pp. 759-762
Authors:
Jantunen, E
Piilonen, A
Volin, L
Parkkali, T
Koukila-Kahkola, P
Ruutu, T
Ruutu, P
Citation: E. Jantunen et al., Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients, BONE MAR TR, 25(8), 2000, pp. 867-871
Authors:
Ruutu, T
Volin, L
Parkkali, T
Juvonen, E
Elonen, E
Citation: T. Ruutu et al., Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study, BLOOD, 96(7), 2000, pp. 2391-2398
Authors:
Gahrton, G
Svensson, H
Bjorkstrand, B
Apperley, J
Carlson, K
Cavo, M
Ferrant, A
Fouillard, L
Gratecos, N
Gratwohl, A
Guilhot, F
Deliliers, GL
Ljungman, P
Masszi, T
Milligan, DW
Powles, RL
Reiffers, J
Samson, JD
Stoppa, AM
Vernant, JP
Volin, L
Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745
Authors:
Parkkali, T
Kayhty, H
Antilla, M
Ruutu, T
Wuorimaa, T
Soininen, A
Volin, L
Ruutu, P
Citation: T. Parkkali et al., IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines, BONE MAR TR, 24(6), 1999, pp. 671-678
Authors:
Valimaki, MJ
Kinnunen, K
Volin, L
Tahtela, R
Loyttyniemi, E
Laitinen, K
Makela, P
Keto, P
Ruutu, T
Citation: Mj. Valimaki et al., A prospective study of bone loss and turnover after allogeneic bone marrowtransplantation: effect of calcium supplementation with or without calcitonin, BONE MAR TR, 23(4), 1999, pp. 355-361
Authors:
Juvonen, E
Aimolahti, A
Volin, L
Ruutu, T
Citation: E. Juvonen et al., The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes, LEUK RES, 23(10), 1999, pp. 889-894
Authors:
Oivanen, T
Ala-Harja, K
Almqvist, A
Apajalahti, J
Elonen, E
Hallman, H
Hanninen, A
Ilvonen, M
Isomaa, B
Jouppila, J
Jarvenpaa, E
Jarventie, G
Kilpi, H
Koistinen, P
Koistinen, S
Koivisto, AM
Koivunen, E
Korpi, E
Katka, K
Kaariainen, M
Lahtinen, R
Laitinen, A
Lehtinen, M
Makela, H
Nylanden, P
Nyman, D
Palva, I
Pelliniemi, TT
Pulli, T
Rajamaki, A
Rauhala, A
Remes, K
Rosengard, S
Ruutu, T
Soininen, K
Tiilikainen, J
Timonen, T
Waris, E
Vilpo, J
Volin, L
Citation: T. Oivanen et al., Long-term survival in multiple myeloma: a Finnish Leukaemia Group study, BR J HAEM, 105(4), 1999, pp. 942-947
Authors:
Ringden, O
Remberger, M
Ruutu, T
Nikoskelainen, J
Volin, L
Vindelov, L
Parkkali, T
Lenhoff, S
Sallerfors, B
Mellander, L
Ljungman, P
Jacobsen, N
Citation: O. Ringden et al., Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia, BLOOD, 93(7), 1999, pp. 2196-2201